Milestone Pharmaceuticals Statistics
Total Valuation
MIST has a market cap or net worth of $97.40 million. The enterprise value is $68.62 million.
| Market Cap | 97.40M |
| Enterprise Value | 68.62M |
Important Dates
The next estimated earnings date is Wednesday, November 11, 2026, before market open.
| Earnings Date | Nov 11, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
MIST has 140.91 million shares outstanding. The number of shares has increased by 77.95% in one year.
| Current Share Class | 124.50M |
| Shares Outstanding | 140.91M |
| Shares Change (YoY) | +77.95% |
| Shares Change (QoQ) | +6.45% |
| Owned by Insiders (%) | 0.80% |
| Owned by Institutions (%) | 24.10% |
| Float | 106.20M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 41.57 |
| Forward PS | 11.50 |
| PB Ratio | 5.35 |
| P/TBV Ratio | 5.35 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 29.29 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.13, with a Debt / Equity ratio of 7.79.
| Current Ratio | 8.13 |
| Quick Ratio | 7.87 |
| Debt / Equity | 7.79 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -7.25 |
Financial Efficiency
Return on equity (ROE) is -35,522.62% and return on invested capital (ROIC) is -49.31%.
| Return on Equity (ROE) | -35,522.62% |
| Return on Assets (ROA) | -42.78% |
| Return on Invested Capital (ROIC) | -49.31% |
| Return on Capital Employed (ROCE) | -49.16% |
| Weighted Average Cost of Capital (WACC) | 7.56% |
| Revenue Per Employee | $61,658 |
| Profits Per Employee | -$2.21M |
| Employee Count | 38 |
| Asset Turnover | 0.02 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.23% in the last 52 weeks. The beta is 1.01, so MIST's price volatility has been similar to the market average.
| Beta (5Y) | 1.01 |
| 52-Week Price Change | -63.23% |
| 50-Day Moving Average | 0.91 |
| 200-Day Moving Average | 1.39 |
| Relative Strength Index (RSI) | 38.26 |
| Average Volume (20 Days) | 977,638 |
Short Selling Information
The latest short interest is 19.71 million, so 13.99% of the outstanding shares have been sold short.
| Short Interest | 19.71M |
| Short Previous Month | 19.01M |
| Short % of Shares Out | 13.99% |
| Short % of Float | 18.56% |
| Short Ratio (days to cover) | 13.18 |
Income Statement
In the last 12 months, MIST had revenue of $2.34 million and -$84.01 million in losses. Loss per share was -$0.71.
| Revenue | 2.34M |
| Gross Profit | 2.30M |
| Operating Income | -78.38M |
| Pretax Income | -84.01M |
| Net Income | -84.01M |
| EBITDA | -78.21M |
| EBIT | -78.38M |
| Loss Per Share | -$0.71 |
Balance Sheet
The company has $170.61 million in cash and $141.83 million in debt, with a net cash position of $28.78 million or $0.20 per share.
| Cash & Cash Equivalents | 170.61M |
| Total Debt | 141.83M |
| Net Cash | 28.78M |
| Net Cash Per Share | $0.20 |
| Equity (Book Value) | 18.22M |
| Book Value Per Share | 0.13 |
| Working Capital | 158.14M |
Cash Flow
In the last 12 months, operating cash flow was -$61.29 million and capital expenditures -$356,000, giving a free cash flow of -$61.65 million.
| Operating Cash Flow | -61.29M |
| Capital Expenditures | -356,000 |
| Depreciation & Amortization | 172,000 |
| Net Borrowing | 74.98M |
| Free Cash Flow | -61.65M |
| FCF Per Share | -$0.44 |
Margins
| Gross Margin | 98.04% |
| Operating Margin | -3,345.24% |
| Pretax Margin | -3,585.62% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
MIST does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -77.95% |
| Shareholder Yield | -77.95% |
| Earnings Yield | -103.03% |
| FCF Yield | -63.29% |
Analyst Forecast
The average price target for MIST is $5.57, which is 705.99% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $5.57 |
| Price Target Difference | 705.99% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (3Y) | 305.21% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
MIST has an Altman Z-Score of -3.4 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.4 |
| Piotroski F-Score | 2 |